CoChat

Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background: Mitochondria are intracellular organelles of bacterial origin capable of stimulating the immune system when released into the extracellular milieu. We previously reported the expression of anti-mitochondrial antibodies (AMA) targeting whole organelles (AwMA), mitochondrial DNA (AmtDNA) or mitochondrial RNA (AmtRNA) in patients with systemic lupus erythematosus (SLE). Antiphospholipid syndrome (APS) is an autoimmune condition that may be independent of, or associated with, other diseases, usually SLE. This study aimed to detect AMA in patients with APS and to explore the association with clinical features of APS. Methods: AwMA-, AmtDNA- and AmtRNA-IgG and -IgM were detected in a pilot study (healthy controls n = 30 and APS patients n = 24) by direct ELISA, and their levels were associated with demographic and disease characteristics. Results: AmtDNA-IgM and AmtRNA-IgG and IgM were elevated in APS compared to healthy controls ( p = 0.009, p = 0.0005 and p = 0.01, respectively). AwMA-IgG were increased in patients positive for lupus anticoagulant (median ± interquartile range = 0.36 ± 0.31 vs. 0.14 ± 0.08, p = 0.008), and optical density values for AwMA-IgM were correlated with titres of IgM against cardiolipin ( r s = 0.51, p = 0.01). An increment of 0.1 unit of AmtDNA-IgM levels was associated with reduced prior reporting of arterial events (odds ratio = 0.86; 95% confidence interval 0.74–1.00; p = 0.047). Conclusion: Our pilot study suggests that AMA are represented within the autoantibody repertoire in APS and may display different associations with the clinical manifestations of the disease. Further studies should focus on reproducing these preliminary results by following AMA levels through time in larger prospective cohorts.

Overview

Integrity signals

Registry

Crossref · 10.1177/0961203320944481

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 15 references

Cited by

See all 11

Metadata

Authors
Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É., & Fortin, P. R.
Affiliations
  • Université Laval (CA)
  • Centre de recherche du CHU de Québec-Université Laval (CA)
Corresponding author
Fortin, Paul R
Venue
Lupus
Published
2020-08-12
Volume
29
Issue
12
Pages
1623-1629
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W3049019850
Cited by
11
References
15
Citations by year
2026: 3 · 2025: 3 · 2023: 1 · 2022: 3 · 2021: 1
FWCI
0.94
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (Foundation Grant 331668)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
antimitochondrial antibodies, antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibodies, arterial events, autoantibody repertoire, systemic lupus erythematosus
MeSH terms
RNA, Mitochondrial, Adult, Aged, Autoantibodies, DNA, Mitochondrial, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Mitochondria, Pilot Projects, Logistic Models, Case-Control Studies, Antiphospholipid Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. https://app.cochat.ai/papers/10.1177/0961203320944481
The paper
Becker, Y. L., Julien, A.-S., Godbout, A., Boilard, É., & Fortin, P. R. (2020). Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome. Lupus. https://doi.org/10.1177/0961203320944481

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.